Skinvisible (SKVI) EBIAT (2016 - 2026)
Skinvisible's EBIAT history spans 16 years, with the latest figure at -$258357.0 for Q4 2025.
- On a quarterly basis, EBIAT fell 182.08% to -$258357.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.1 million, a 88.11% decrease, with the full-year FY2025 number at -$1.1 million, down 88.11% from a year prior.
- EBIAT hit -$258357.0 in Q4 2025 for Skinvisible, down from -$250245.0 in the prior quarter.
- Over the last five years, EBIAT for SKVI hit a ceiling of $314771.0 in Q4 2024 and a floor of -$1.5 million in Q1 2023.
- Historically, EBIAT has averaged -$315488.4 across 5 years, with a median of -$278540.0 in 2023.
- Biggest five-year swings in EBIAT: crashed 606.26% in 2023 and later soared 203.61% in 2024.
- Tracing SKVI's EBIAT over 5 years: stood at -$165382.0 in 2021, then crashed by 142.21% to -$400577.0 in 2022, then grew by 24.16% to -$303791.0 in 2023, then soared by 203.61% to $314771.0 in 2024, then tumbled by 182.08% to -$258357.0 in 2025.
- Business Quant data shows EBIAT for SKVI at -$258357.0 in Q4 2025, -$250245.0 in Q3 2025, and -$274427.0 in Q2 2025.